High-mobility group box 1 and cancer

被引:445
作者
Tang, Daolin [1 ]
Kang, Rui [1 ]
Zeh, Herbert J., III [1 ]
Lotze, Michael T. [1 ]
机构
[1] Univ Pittsburgh, G27A Hillman Canc Ctr, Inst Canc, DAMP Lab,Dept Surg, Pittsburgh, PA 15213 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS | 2010年 / 1799卷 / 1-2期
关键词
HMGB1; Damage associated molecular pattern molecule [DAMP; Autophagy; Cancer; Angiogenesis; Receptor for advanced glycation endproducts [RAGE; TLR2; TLR4; CD24; TLR9; Hallmarks of cancer; Field effect; Inflammation; GLYCATION END-PRODUCTS; SQUAMOUS-CELL CARCINOMA; MOLECULAR-PATTERN MOLECULES; CHROMATIN PROTEIN HMGB1; CISPLATIN-MODIFIED DNA; NUCLEAR FACTOR HMGB1; GROUP-B PROTEINS; BREAST-CANCER; ETHYL PYRUVATE; ESTROGEN-RECEPTOR;
D O I
10.1016/j.bbagrm.2009.11.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High-mobility group box 1 protein (HMGB1), a chromatin associated nuclear protein and extracellular damage associated molecular pattern molecule (DAMP), is an evolutionarily ancient and critical regulator of cell death and survival. Overexpression of HMGB1 is associated with each of the hallmarks of cancer including unlimited replicative potential, ability to develop blood vessels (angiogenesis), evasion of programmed cell death (apoptosis), self-sufficiency in growth signals, insensitivity to inhibitors of growth, inflammation, tissue invasion and metastasis. Our studies and those Of Our Colleagues Suggest that HMGB1 is central to cancer (abnormal Wound healing) and many of the findings in normal Wound healing as well. Here, we focus on the role of HMGB1 in cancer, the mechanisms by which it contributes to carcinogenesis, and therapeutic strategies based on targeting HMGB1. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:131 / 140
页数:10
相关论文
共 157 条
[51]   Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development [J].
Ishiguro, H ;
Nakaigawa, N ;
Miyoshi, Y ;
Fujinami, K ;
Kubota, Y ;
Uemura, H .
PROSTATE, 2005, 64 (01) :92-100
[52]   Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils [J].
Ito, Ichiaki ;
Fukazawa, Jutarou ;
Yoshida, Michiteru .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (22) :16336-16344
[53]   Cytolytic cells induce HMGB1 release from melanoma cell lines [J].
Ito, Norimasa ;
DeMarco, Richard A. ;
Mailliard, Robbie B. ;
Han, Jie ;
Rabinowich, Hannah ;
Kalinski, Pawel ;
Stolz, Donna Beer ;
Zeh, Herbert J., III ;
Lotze, Michael T. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 81 (01) :75-83
[54]   NUCLEOLAR TRANSCRIPTION FACTOR HUBF CONTAINS A DNA-BINDING MOTIF WITH HOMOLOGY TO HMG PROTEINS [J].
JANTZEN, HM ;
ADMON, A ;
BELL, SP ;
TJIAN, R .
NATURE, 1990, 344 (6269) :830-836
[55]   High mobility group protein-1 (HMG-1) is a unique activator of p53 [J].
Jayaraman, L ;
Moorthy, NC ;
Murthy, KGK ;
Manley, JL ;
Bustin, M ;
Prives, C .
GENES & DEVELOPMENT, 1998, 12 (04) :462-472
[56]   Growth suppression and radiosensitivity increase by HMGB1 in breast cancer [J].
Jiao, Yang ;
Wang, Hai-chao ;
Fan, Sai-jun .
ACTA PHARMACOLOGICA SINICA, 2007, 28 (12) :1957-1967
[57]   Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions - Role of activated macrophages and cytokines [J].
Kalinina, N ;
Agrotis, A ;
Antropova, Y ;
DiVitto, G ;
Kanellakis, P ;
Kostolias, G ;
Ilyinskaya, O ;
Tararak, E ;
Bobik, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (12) :2320-2325
[58]   Non-histone nuclear factor HMGB1 is phosphorylated and secreted in colon cancers [J].
Kang, Hyun Ju ;
Lee, Hanna ;
Choi, Hee-Jung ;
Youn, Ju Ho ;
Shin, Jeon-Soo ;
Ahn, Yeong Hee ;
Yoo, Jong Shin ;
Paik, Young-Ki ;
Kim, Hoguen .
LABORATORY INVESTIGATION, 2009, 89 (08) :948-959
[59]  
KANG R, 2009, CELL DEATH DIFF 1016
[60]  
Kang Rui, 2007, Zhonghua Er Ke Za Zhi, V45, P329